|Bid||N/A x N/A|
|Ask||N/A x N/A|
|Day's Range||N/A - N/A|
|52 Week Range||undefined - undefined|
|PE Ratio (TTM)||N/A|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Click here to see latest analysisArrhythmia Research Technology, Inc. reports financial results for the quarter ended September 30, 2015.We analyze the earnings along side the following peers of Arrhythmia Research Technology, Inc. – Sparton Corporation, Greatbatch, Inc., Teligent, Inc., VirtualScopics, Inc. and Elite Pharmaceuticals, Inc. (SPA-US, GB-US, TLGT-US, VSCP-US and ELTP-US) that have also reported […] (Read more...) The post Arrhythmia Research Technology, Inc. Earnings Q3, 2015 appeared first on CapitalCube.
Arrhythmia Research Tech (HRT) has been upgraded by TheStreet Ratings from Sell to Hold with a ratings score of C.